DE69832197D1 - Rantes mutanten und deren therapeutische verwendungen - Google Patents

Rantes mutanten und deren therapeutische verwendungen

Info

Publication number
DE69832197D1
DE69832197D1 DE69832197T DE69832197T DE69832197D1 DE 69832197 D1 DE69832197 D1 DE 69832197D1 DE 69832197 T DE69832197 T DE 69832197T DE 69832197 T DE69832197 T DE 69832197T DE 69832197 D1 DE69832197 D1 DE 69832197D1
Authority
DE
Germany
Prior art keywords
rantes
therapeutic uses
rantes mutants
mutants
wild
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69832197T
Other languages
English (en)
Other versions
DE69832197T2 (de
Inventor
Paolo Lusso
Simona Polo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SAN RAFFAELE CENTRO FOND
Original Assignee
SAN RAFFAELE CENTRO FOND
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI972865 external-priority patent/IT1297015B1/it
Priority claimed from IT98MI001866 external-priority patent/IT1302012B1/it
Application filed by SAN RAFFAELE CENTRO FOND filed Critical SAN RAFFAELE CENTRO FOND
Publication of DE69832197D1 publication Critical patent/DE69832197D1/de
Application granted granted Critical
Publication of DE69832197T2 publication Critical patent/DE69832197T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69832197T 1997-12-23 1998-12-21 Rantes-mutanten und therapeutische anwendungen davon Expired - Lifetime DE69832197T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
ITMI972865 IT1297015B1 (it) 1997-12-23 1997-12-23 Mutanti di rantes e loro applicazioni terapeutiche
ITMI972865 1997-12-23
ITMI981866 1998-08-07
IT98MI001866 IT1302012B1 (it) 1998-08-07 1998-08-07 Derivati di rantes e loro applicazioni terapeutiche.
PCT/EP1998/008354 WO1999033989A2 (en) 1997-12-23 1998-12-21 Rantes mutants and therapeutic applications thereof

Publications (2)

Publication Number Publication Date
DE69832197D1 true DE69832197D1 (de) 2005-12-08
DE69832197T2 DE69832197T2 (de) 2006-05-24

Family

ID=26331556

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69832197T Expired - Lifetime DE69832197T2 (de) 1997-12-23 1998-12-21 Rantes-mutanten und therapeutische anwendungen davon
DE69832216T Expired - Lifetime DE69832216T2 (de) 1997-12-23 1998-12-21 RANTES-Mutanten und therapeutische Anwendungen davon

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69832216T Expired - Lifetime DE69832216T2 (de) 1997-12-23 1998-12-21 RANTES-Mutanten und therapeutische Anwendungen davon

Country Status (10)

Country Link
US (2) US6608177B1 (de)
EP (2) EP1040191B1 (de)
JP (1) JP4323094B2 (de)
AT (2) ATE308616T1 (de)
AU (1) AU2415599A (de)
CA (1) CA2316447C (de)
DE (2) DE69832197T2 (de)
DK (2) DK1040191T3 (de)
ES (2) ES2247475T3 (de)
WO (1) WO1999033989A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743594B1 (en) 1995-06-06 2004-06-01 Human Genome Sciences, Inc. Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5)
US6025154A (en) 1995-06-06 2000-02-15 Human Genome Sciences, Inc. Polynucleotides encoding human G-protein chemokine receptor HDGNR10
UA77950C2 (en) * 2000-10-04 2007-02-15 Applied Research Systems Use of mutants of cc chemokines for treatment of multiple sclerosis
AU2002358144B2 (en) 2001-12-17 2008-10-02 Laboratoires Serono Sa Chemokine mutants acting as chemokine antagonists
AU2003240758B2 (en) * 2002-04-04 2008-03-13 Laboratoires Serono Sa Chemokines mutants having improved oral bioavailability
EP2091971A4 (de) * 2006-11-13 2010-05-05 Functional Genetics Inc Therapeutisches targeting von escort-proteinen
EP2185719B1 (de) 2007-08-02 2013-11-13 NovImmune SA Rantes-antikörper und verfahren zu ihrer verwendung
CA3101052A1 (en) 2018-05-28 2019-12-05 ORION Biotechnology Switzerland Sarl Methods of inhibiting cerebral inflammation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9703889A (es) * 1994-12-08 1997-08-30 Glaxo Group Ltd Peptido rantes y fragmentos y composiciones que lo contienen, para el tratamiento de la inflamacion.
FR2748938B1 (fr) * 1996-05-22 1998-07-31 Pasteur Institut Utilisation de molecules antagonistes de chemokines pour leur activite antivirale notamment contre un retrovirus de type vih
EP0972043A1 (de) * 1996-09-25 2000-01-19 British Biotech Pharmaceuticals Limited Mutanten von humanem rantes, die keine aggregate bilden können

Also Published As

Publication number Publication date
EP1431391B1 (de) 2005-11-02
US20030216549A1 (en) 2003-11-20
JP2002507388A (ja) 2002-03-12
WO1999033989A2 (en) 1999-07-08
CA2316447A1 (en) 1999-07-08
DE69832197T2 (de) 2006-05-24
EP1040191A2 (de) 2000-10-04
ES2247475T3 (es) 2006-03-01
WO1999033989A3 (en) 1999-08-26
DK1431391T3 (da) 2005-12-19
JP4323094B2 (ja) 2009-09-02
AU2415599A (en) 1999-07-19
EP1040191B1 (de) 2005-11-02
DK1040191T3 (da) 2005-12-19
DE69832216T2 (de) 2006-05-24
ATE308616T1 (de) 2005-11-15
CA2316447C (en) 2009-07-28
US7164000B2 (en) 2007-01-16
DE69832216D1 (de) 2005-12-08
ATE308617T1 (de) 2005-11-15
EP1431391A3 (de) 2004-10-06
US6608177B1 (en) 2003-08-19
ES2247738T3 (es) 2006-03-01
EP1431391A2 (de) 2004-06-23

Similar Documents

Publication Publication Date Title
ATE185602T1 (de) Verändertes menschliches il-6
DE69731373D1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
ATE211467T1 (de) 4-amino-derivate der mycophenolsäure mit immun suppressiver wirkung
TR200002773T2 (tr) Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı.
NO911624D0 (no) Farmasoeytiske forbindelser.
PH31441A (en) 5.Substituted derivatives of mycophenolic acid.
DE69033703D1 (de) Nichtglykosyliertes fgf-4 und dieses enthaltende präparate
ES2177625T3 (es) Citoquina cc-1 humana circulante.
ATE308616T1 (de) Rantes mutanten und deren therapeutische verwendungen
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
BG103543A (en) The use of pramipexol in the treatment of the uneasy legs syndrome
ATE210126T1 (de) 4-amino-6-substituierte mycophenolsäurederivate mit immunsuppressiver wirkung
DK0647654T3 (da) Anomere fluor-ribosylaminer
IT1244880B (it) Formulazioni di amminoacidi liofilizzati contenenti glutammina, loro preparazione ed uso nell'alimentazione parenterale
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
IT8840172A0 (it) Procedimento e mezzi per l'impressione in rilievo di tessuti, o pelli e simili
DE3689850D1 (de) Peptide und deren Verwendung in der Therapie.
Palani Professor Dr. N. Subbu Reddiar's contributions for the enrichment of Tamil
ES2127133A1 (es) Utilizacion de derivados 2,5-dihidroxibencenosulfonicos para la fabricacion de medicamentos destinados al tratamiento y a la prevencion de la enfermedad de alzheimer.
IT1230707B (it) Pirimidine 2 4 disostituite loro preparazione ed impieghi terapeutici.
ITRM920079A1 (it) Manufatto per l'allargamento di banchine stradali e procedimento di posa in opera.
IT1268425B1 (it) Sistema, per strumenti musicali e simili, in grado di interagire con l'utente segnalandogli, mediante illuminazioni, la corretta
ITRM930343A0 (it) Proteine ricombinanti, vettori per l'espressione e loro usi.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition